INTS vs ZBH · $7.7M cap vs P/E 23, rev $7.68B
Intensity Therapeutics, Inc. Common stock (INTS) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
INTS does not have a complete income-statement cache yet.
Latest reported ZBH revenue for 2024-12-31 was $7.68B. Net income was $905.3M. Revenue was up 3.8% from 2023-12-31 to 2024-12-31. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
INTS currently screens at market cap $7.7M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the INTS and ZBH stock pages for the full models.
Not investment advice.